Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Gil M, Lewitus"'
Autor:
Shiraz Vered, Alexa S. Beiser, Liron Sulimani, Sharon Sznitman, Mitzi M. Gonzales, Hugo J. Aparicio, Charles DeCarli, Matthew R. Scott, Saptaparni Ghosh, Gil M. Lewitus, David Meiri, Sudha Seshadri, Galit Weinstein
Publikováno v:
Alzheimer’s Research & Therapy, Vol 15, Iss 1, Pp 1-11 (2023)
Abstract Background Preclinical studies highlight the importance of endogenous cannabinoids (endocannabinoids; eCBs) in neurodegeneration. Yet, prior observational studies focused on limited outcome measures and assessed only few eCB compounds while
Externí odkaz:
https://doaj.org/article/093f68cbea874b4aa79ffe745a7b724d
Autor:
Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Mahmoud Abu Amna, Anton Ouryvaev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Luiza Akria, Dimitry Goncharov, Neomi Mativ, Avia Kauffman, Ayelet Shai, Gil Bar-Sela, David Meiri
Publikováno v:
Frontiers in Pain Research, Vol 3 (2022)
The use of medical cannabis (MC) to treat cancer-related symptoms is rising. However, there is a lack of long-term trials to assess the benefits and safety of MC treatment in this population. In this work, we followed up prospectively and longitudina
Externí odkaz:
https://doaj.org/article/0e62212239e74aa79ad8acd7045b712e
Autor:
Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Ben Yellin, Paula Berman, Anna Shapira, David Meiri
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Introduction: Chronic non-cancer pain (CNCP) is one of the most prevalent indications for medical cannabis (MC) treatment globally. In this study, we investigated CNCP parameters in patients during prolonged MC treatment, and assessed the interrelati
Externí odkaz:
https://doaj.org/article/4aae674fae834d45b53b611b07ab17dc
Autor:
Jeffrey Y. Hergenrather, Joshua Aviram, Yelena Vysotski, Salvatore Campisi-Pinto, Gil M. Lewitus, David Meiri
Publikováno v:
Rambam Maimonides Medical Journal, Vol 11, Iss 1, p e0001 (2020)
Objective The aim of this cross-sectional questionnaire-based study was to identify associations between the doses of cannabinoids and terpenes administered, and symptoms of attention deficit hyperactivity disorder (ADHD). Methods Participants wer
Externí odkaz:
https://doaj.org/article/e7279373bdff4449bf6ca6ae83aa87f4
Autor:
Joshua Aviram, Gil M. Lewitus, Yelena Vysotski, Anton Uribayev, Shiri Procaccia, Idan Cohen, Anca Leibovici, Mahmud Abo-Amna, Luiza Akria, Dmitry Goncharov, Neomi Mativ, Avia Kauffman, Ayelet Shai, Or Hazan, Gil Bar-Sela, David Meiri
Publikováno v:
Pharmaceuticals, Vol 13, Iss 12, p 435 (2020)
In the last decade the use of medical cannabis (MC) for palliative cancer treatment has risen. However, the choice between products is arbitrary and most patients are using Tetrahydrocannabinol (THC)-dominant cannabis products. In this study, we aime
Externí odkaz:
https://doaj.org/article/d74e246789a745cbb048bc92c942b028
Publikováno v:
Brain Sciences, Vol 10, Iss 6, p 360 (2020)
Background: Medical cannabis (MC) treatment for migraine is practically emerging, although sufficient clinical data are not available for this indication. This cross-sectional questionnaire-based study aimed to investigate the associations between ph
Externí odkaz:
https://doaj.org/article/f92021260f344f8988440ecba7e2a5d5
Autor:
Shiri Procaccia, David Meiri, Joshua Aviram, Paula Berman, Yelena Vysotski, Gil M. Lewitus, Anna Shapira
Publikováno v:
Pain. 163:975-983
Studies have shown that women are more susceptible to adverse effects (AEs) from conventional drugs. This study aimed to investigate the differences of medical cannabis (MC)-related AEs between women and men in patients with chronic noncancer pain (C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c147bad6f4aea8f01d36088351eb712b
https://doi.org/10.1097/j.pain.0000000000002463
https://doi.org/10.1097/j.pain.0000000000002463
Autor:
Julien Chambon, Pragya Komal, Gil M. Lewitus, Gina M. Kemp, Simone Valade, Houaria Adaïdi, Noura Al Bistami, David Stellwagen
Publikováno v:
The Journal of neuroscience : the official journal of the Society for Neuroscience.
Huntington's disease (HD) is a neurodegenerative disease caused by a polyglutamine expansion in the huntingtin gene. Neurodegeneration first occurs in the striatum, accompanied by an elevation in inflammatory cytokines. Using the presymptomatic male
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7fcdd4f5b14dba5156e545f40ac749b
https://pubmed.ncbi.nlm.nih.gov/36517241
https://pubmed.ncbi.nlm.nih.gov/36517241
Autor:
Ella Peled, Elazar Besser, Paula Berman, Liran Baram, Gil M. Lewitus, Igal Louria-Hayon, Ben Yellin, David Meiri, Maya Benami
Publikováno v:
Oncotarget. 10:4091-4106
The Cannabis plant contains over 100 phytocannabinoids and hundreds of other components. The biological effects and interplay of these Cannabis compounds are not fully understood and yet influence the plant's therapeutic effects. Here we assessed the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c746237bfb185531691c70468aa3d067
https://doi.org/10.18632/oncotarget.26983
https://doi.org/10.18632/oncotarget.26983
Autor:
Paula Berman, David Meiri, Yelena Vysotski, Joshua Aviram, Ben Yellin, Anna Shapira, Gil M. Lewitus
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
Introduction:Chronic non-cancer pain (CNCP) is one of the most prevalent indications for medical cannabis (MC) treatment globally. In this study, we investigated CNCP parameters in patients during prolonged MC treatment, and assessed the interrelatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ccebf6ff5341bc7881af6bfd1fda82b
https://www.frontiersin.org/articles/10.3389/fphar.2021.613805/full
https://www.frontiersin.org/articles/10.3389/fphar.2021.613805/full